The rise and fall of poly(ADP-ribose): An enzymatic perspective

DNA Repair

Volumn 32, Issue , 2015, Pages 10-16

  Pascal, John M ^a   Ellenberger, Tom ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADP ribose; DNA damage response; MARG; PARG; PARP; Poly(ADP ribose)

Indexed keywords

POLY(ADENOSINE DIPHOSPHATE RIBOSE); DNA; GLYCOSIDASE; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ARTICLE; CELL FATE; DNA DAMAGE; ENZYME ANALYSIS; ENZYME METABOLISM; ENZYME STRUCTURE; ENZYME SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; CHEMISTRY; DNA REPAIR; ENZYME SPECIFICITY; METABOLISM; MOLECULAR MODEL; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

DNA; DNA DAMAGE; DNA REPAIR; GLYCOSIDE HYDROLASES; HUMANS; ISOENZYMES; MODELS, MOLECULAR; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

EID: 84938198958     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2015.04.008     Document Type: Article

References (75)

1. Amé J.-C., Spenlehauer C., de.Murcia G. The PARP superfamily. Bioessays 2004, 26:882-893. 10.1002/bies.20085.
2. Žaja R., Mikoč A., Barkauskaite E., Ahel I. Molecular Insights into Poly(ADP-ribose) 2015.
3. Krietsch J., Rouleau M., Pic É., Ethier C., Dawson T.M., Dawson V.L., et al. Reprogramming cellular events by poly(ADP-ribose)-binding proteins. Mol. Aspects Med. 2013, 34:1066-1087. 10.1016/j.mam.2012.12.005.
4. Leung A.K.L. Poly(ADP-ribose): an organizer of cellular architecture. J. Cell Biol. 2014, 205:613-619. 10.1083/jcb.201402114.
5. Malanga M., Althaus F.R. Noncovalent protein interaction with poly(ADP-ribose). Methods Mol. Biol. 2011, 780:67-82. 10.1007/978-1-61779-270-0-5.
6. Gagné J.-P., Pic É., Isabelle M., Krietsch J., Ethier C., Paquet E., et al. Quantitative proteomics profiling of the poly(ADP-ribose)-related response. Nucleic Acids Res. 2012, 40:7788-7805. 10.1093/nar/gks486.
7. Jungmichel F., Rosenthal M., Altmeyer J., Lukas M.O. Proteome-wide identification of poly(ADP-Ribosyl) ation targets in different genotoxic stress responses. Mol. Cell 2013, 10.1016/j.molcel.2013.08.026.
8. Feng X., Koh D.W. Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis. Int. Rev. Cell Mol. Biol. 2013, 304:227-281. 10.1016/B978-0-12-407696-9 5-1.
9. Min W., Wang Z.-Q. Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential. Front. Biosci. 2009, 14:1619-1626. 10.2741/3329.
10. De Vos M., MSchrieber V., Dantzer F. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem. Pharmacol. 2012, 84:137-146. 10.1016/j.bcp.2012.03.018.
11. Caldecott K.W. Protein ADP-ribosylation and the cellular response to DNA strand breaks. DNA Repair (Amst.) 2014, 19:108-113. 10.1016/j.dnarep.2014.03.021.
12. Barkauskaite G., Jankevicius A.G., Ladurner I. The recognition and removal of cellular poly(ADP-ribose) signals. FEBS J. 2013, 280:3491-3507. 10.1111/febs.12358.
13. Karlberg T., Langelier M.-F., Pascal J.M., Schüler H. Structural biology of the writers, readers, and erasers in mono- and poly(ADP-ribose) mediated signaling. Mol. Aspects Med. 2013, 34:1088-1108. 10.1016/j.mam.2013.02.002.
14. Ruf A., Mennissier de Murcia J., de Murcia G., Schulz G.E. Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken. Proc. Natl. Acad. Sci. 1996, 93:7481-7485. 10.1073/pnas.93.15.7481.
15. + binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling. Biochemistry 1998, 37:3893-3900. 10.1021/bi972383s.
16. Steffen J.D., Brody J.R., Armen R.S., Pascal J.M. Structural Implications for selective targeting of PARPs. Front Oncol. 2013, 3(301):1-14.
17. Hottiger P.O., Lüscher B., Schüler H., Koch-Nolte F. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends. Biochem. Sci. 2010, 35:208-219. 10.1016/j.tibs.2009.12.003.
18. Vyas S., Matic I., Uchima L., Rood J., Žaja R., Hay R.T., et al. Family-wide analysis of poly(ADP-ribose) polymerase activity. Nat. Commun. 2014, 4426:1-13. 10.1038/ncomms5426.
19. Langelier M.-F., Planck J.L., Roy S., Pascal J.M. Structural Basis for DNA damage-dependent poly(ADP-ribosyl) ation by human PARP-1. Science 2012, 336:728-732. 10.1126/science.1216338.
20. Langelier M.-F., Riccio A.A., Pascal J.M. PARP-2 and PARP-3 are selectively activated by 5' phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1. Nucleic Acids Res. 2014, 42:7762-7775. 10.1093/nar/gku474.
21. Rulten S.L., Fisher A.E.O., Robert M.C., Zuma M., Ju L., et al. PARP-3 and APLF function together to accelerate nonhomologous end-joining. Mol. Cell 2011, 41:33-45. 10.1016/j.molcel.2010.12.006.
22. Langelier M.-F., Pascal J.M. PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis. Curr. Opin. Struct. Biol. 2013, 23:134-143. 10.1016/j.sbi.2013.01.003.
23. Steffen J.D., Pascal J.M. New players to the field of ADP-ribosylation make the final cut. EMBO J. 2013, 32:1205-1207. 10.1038/emboj.2013.83.
24. Steffen J.D., Tholey R.M., Langelier M.-F., Planck J.L., Schiewer M.J., Lal S., et al. Targeting PARP-1 allosteric regulation offers therapeutic potential against cancer. Cancer Res. 2013, 74:31-37. 10.1158/0008-5472 CAN-13-1701.
25. Langelier M.-F., Planck J.L., Roy S., Pascal J.M. Crystal structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers bound to DNA: structural and functional insights into DNA-dependent PARP-1 activity. J. Biol. Chem. 2011, 286(10):690-10701. 10.1074/jbc.M110.202507.
26. Ali A.A.E., Timinszky G., Arribas-Bosacoma R., Kozlowski M., Hassa P.O., Hassler M., et al. The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks. Nat. Struct. Mol. Biol. 2012, 19:685-692. 10.1038/nsmb.2335.
27. Lilyestrom W., van der Woerd M.J., Clark N., Luger K. Structural and biophysical studies of human PARP-1 in complex with damaged DNA. J. Mol. Biol. 2010, 395:983-994. 10.1016/j.jmb.2009.11.062.
28. Eustermann S., Videler H., Yang P.T., Gruszka D., Veprintsev D., et al. The DNA-binding domain of human PARP-1 interacts with DNA single-strand breaks as a monomer through its second zinc finger. J. Mol. Biol. 2011, 407:149-170. 10.1016/j.jmb.2011.01.034.
29. Mansoorabadi S.O., Wu Z., Guo L., et al. Conformational activation of poly(ADP-ribose) polymerase-1 upon DNA binding revealed by small-angle X-ray scattering. Biochemistry 2014, 53:1779-1788. 10.1021/bi401439n.
30. Spagnolo L., Barbeau J., Curtin N.J., Morris E.P., Pearl L.H. Visualization of a DNA-PK/PARP1 complex. Nucleic Acids Res. 2012, 40:4168-4177. 10.1093/nar/gkr1231.
31. Zilio N., Williamson C.T., Eustermann S., Shah R., West S.C., Neuhaus D., et al. DNA-dependent SUMO modification of PARP-1. DNA Repair (Amst.) 2013, 12:761-773. 10.1016/j.dnarep.2013.07.001.
32. Clark N.J., Kramer M., Muthurajan U.M., Luger K. Alternative modes of binding of poly(ADP-ribose) polymerase 1 to free DNA and nucleosomes. J. Bio. Chem. 2012, 287(32):430-32439. 10.1074/jbc.M112.397067.
33. Sharifi R., Morra R., Appel C.D., Tallis M. Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease. EMBO J. 2013, 32:1225-1237. 10.1038/emboj.2013.51.
34. Chapman J.D., Gagné J.-P., Poirier G.G., Goodlett D.R. Mapping PARP-1 auto-ADP-ribosylation sites by liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2013, 12:1868-1880. 10.1021/pr301219h.
35. Tao Z., Gao P., Liu H.W. Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications. J. Am. Chem. Soc. 2009, 131(14):258-14260. 10.1021/ja906135d.
36. Zhang X., Claerhout S., Prat A., Dobrolecki L.E., Petrovic I., Lai Q., et al. A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models. Cancer Res. 2013, 73:4885-4897. 10.1158/0008-5472.
37. Daniels C.M., Ong S.-E., Leung A.K.L. Phosphoproteomic approach to characterize protein mono- and poly(ADP-ribosyl) ation sites from cells. J. Proteome Res. 2014, 13:3510-3522. 10.1021/pr401032q.
38. Ström C.E., Johansson F., Uhlén M., Szigyarto C.A.-K., Erixon K., Helleday T. Poly(ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate. Nucleic Acids Res. 2011, 39:3166-3175. 10.1093/nar/gkq1241.
39. Murai J., Huang S.Y., Das B.B., Renaud A., Zhang Y., Doroshow J.H., et al. Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Cancer Res. 2012, 72:5588-5599. 10.1158/0008-5472 CAN-12-2753.
40. Rosenthal F., Feijs K.L.H., Frugier E., Bonalli M., Forst A.H., Imhof R., et al. Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. Nat. Struct. Mol. Biol. 2013, 20:502-507. 10.1038/nsmb.2521.
41. Gao H., Coyle D.L., Meyer-Ficca M.L., Meyer R.G., Jacobson E.L., Wang Z.-Q., et al. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase. Exp. Cell Res. 2007, 313:984-996. 10.1016/j.yexcr.2006.12.025.
42. Fathers C., Drayton R.M., Solovieva S., Bryant H.E. Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells. Cell Cycle 2012, 11:990-997. 10.4161/cc.11.5.19482.
43. Slade D., Dunstan M.S., Barkauskaite E., Weston R., Lafite P., Dixon N., et al. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature 2011, 477:616-620. 10.1038/nature10404.
44. Kim I.-K., Kiefer J.R., Ho C.M.W., Stegeman R.A., Classen S., Tainer J.A., et al. Structure of mammalian poly(ADP-ribose) glycohydrolase reveals a flexible tyrosine clasp as a substrate-binding element. Nat. Struct. Mol. Biol. 2012, 19:653-656. 10.1038/nsmb.2305.
45. Dunstan M.S., Barkauskaite E., Lafite P., Knezevic C.E., Brassington A., Ahel M., et al. Structure and mechanism of a canonical poly(ADP-ribose) glycohydrolase. Nat. Commun. 2012, 3:878. 10.1038/ncomms1889.
46. Tucker J.A., Bennett N., Brassington C., Durant G., Holdgate G., et al. Structures of the human poly (ADP-Ribose) glycohydrolase catalytic domain confirm catalytic mechanism and explain inhibition by ADP-HPD derivatives. PLos One 2012, 7:e50889. 10.1371/journal.pone.0050889.
47. Wang Z., Gagné J.P., Poirier G.G., Xu W. PLOS ONE: crystallographic and biochemical analysis of the mouse poly(ADP-ribose) glycohydrolase. PLos One 2014, 10.1371/journal.pone.0086010 g005.
48. Pehrson J.R., Fried V.A. MacroH2A, a core histone containing a large nonhistone region. Science 1992, 257:1398-1400.
49. Karras G.I., Kustatscher G., Buhecha H.R., Allen M.D., Pugieux C., Sait F., et al. The macro domain is an ADP-ribose binding module. EMBO J. 2005, 24:1911-1920. 10.1038/sj.emboj.7600664.
50. Andrabi S.A., Kim N.S., Yu S.-W., Wang H., Koh D.W., Sasaki M., et al. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(18):18308-18313. 10.1073/pnas.0606526103.
51. Yu S.-W., Andrabi S.A., Wang H., Kim N.S., Poirier, G.G., Dawson T.M., et al. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(18):18314-18319. 10.1073/pnas.0606528103.
52. Barkauskaite E., Brassington A., Tan E.S., Warwicker J., Dunstan M.S., Banos B., et al. Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities. Nat. Commun. 2013, 4. 10.1038/ncomms3164.
53. Rempel B.P., Withers S.G. Covalent inhibitors of glycosidases and their applications in biochemistry and biology. Glycobiology 2008, 18:570-586. 10.1093/glycob/cwn041.
54. Gloster T.M., Davies G.J. Glycosidase inhibition: assessing mimicry of the transition state. Org. Biomol. Chem. 2010, 8:305-320. 10.1039/B915870G.
55. Slama J.T., Aboul-Ela N., Goli D.M., Cheesman B.V., Simmons A.M., Jacobson M.K. Specific inhibition of poly(ADP-ribose) glycohydrolase by adenosine diphosphate (hydroxymethyl) pyrrolidinediol. J. Med. Chem. 1995, 38:389-393.
56. Liu C., Wu J., Paudyal S.C., You Z., Yu X. CHFR is important for the first wave of ubiquitination at DNA damage sites. Nucleic Acids Res. 2013, 41:1698-1710. 10.1093/nar/gks1278.
57. Amé J.-C., Fouquerel E., Gauthier L.R., Biard F.D., Dantzer F., et al. Radiation-induced mitotic catastrophe in PARG-deficient cells. J. Cell Sci. 2009, 122:1990-2002. 10.1242/jcs.039115.
58. Koh D.W., Lawler A.M., Poitras M.F., Sasaki M., Wattler S., Nehls M.C., et al. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(17):17699-17704. 10.1073/pnas.0406182101.
59. Fujihara H., Ogino H., Maeda D., Shirai H., Nozaki T., Kamada N., et al. Poly(ADP-ribose) glycohydrolase deficiency sensitizes mouse ES cells to DNA damaging agents. Curr. Cancer Drug Targets 2009, 9:953-962. 10.2174/156800909790192419.
60. Sevrioukova I.F. Apoptosis-inducing factor: structure, function, and redox regulation. Antioxid. Redox Signal. 2011, 14:2545-2579. 10.1089/ars.2010.3445.
61. Fatokun A.A., Dawson V.L., Dawson T.M. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br. J. Pharmacol. 2014, 171:2000-2016. 10.1111/bph.12416.
62. Delavallèe L., Cabon L., Galán-Malo P., Lorenzo H.K., Susin S.A. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life 2011, 63:221-232. 10.1002/iub.432.
63. Aredia F., Scovassi A.I. Poly(ADP-ribose): a signaling molecule in different paradigms of cell death. Biochem. Pharmacol. 2014, 92:157-163. 10.1016/j.bcp.2014.06.021.
64. Wang Y., Kim N.S., Haince J.-F., Kang H.C., David K.K., Andrabi S.A., et al. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci. Signal. 2011, 4:ra20-14. 10.1126/scisignal.2000902.
65. Guse A.H. Calcium mobilizing second messengers derived from NAD. Biochim. Biophys. Acta 2014, 10.1016/j.bbapap.2014.12.015.
66. Yang K.-T., Chang W.-L., Yang P.-C., Chien C.-L., Lai, M.-S., Su M.-J., et al. Activation of the transient receptor potential M2 channel and poly(ADP-ribose) polymerase is involved in oxidative stress-induced cardiomyocyte death. Cell Death Differ. 2006, 13:1815-1826. 10.1038/sj.cdd.4401813.
67. Yamamoto S., Takahashi N., Mori Y. Chemical physiology of oxidative stress-activated TRPM2 and TRPC5 channels. Prog. Biophys. Mol. Biol. 2010, 103:18-27. 10.1016/j.pbiomolbio.2010.05.005.
68. 2+ fluxes in oxidative cell death. Cell. Moll. Life Sci. 2011, 68:1455-1466. 10.1007/s00018-010-0533-1.
69. Sumoza-Toledo A., Penner R. TRPM2: a multifunctional ion channel for calcium signalling. J. Physiol. (Lond.) 2011, 589:1515-1525. 10.1113/jphysiol.2010.201855.
70. Shen B.W., Perraud A.-L., Scharenberg A., Stoddard B.L. The crystal structure and mutational analysis of human NUDT9. J. Mol. Biol. 2003, 332:385-398.
71. 2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ. 2008, 15:1857-1864. 10.1038/cdd.2008.123.
72. Lord C.J., Tutt A.N.J., Ashworth A. Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors. Annu. Rev. Med. 2015, 66:455-470. 10.1146/annurev-med-050913-022545.
73. Blenn C., Wyrsch P., Althaus F.R. The Ups and downs of tannins as inhibitors of poly(ADP-ribose) glycohydrolase. Molecules 2011, 16:1854-1877. 10.1146/annurev-med-050913-022545.
74. Curtin N.J., Szabó C. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol. Aspects Med. 2013, 34:1217-1256. 10.1016/j.mam.2013.01.006.
75. Pearl L.H., Schierz A.C., Ward S.E., Al-Lazikani B., Pearl F.M.G. Therapeutic opportunities within the DNA damage response. Nat. Rev. Cancer 2015, 15:166-180. 10.1038/nrc3891.